These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 9723458

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Impact of OKT3 treatment for steroid resistant rejection of renal allografts: the long-term outcome at a single center.
    Inui M, Tanabe K, Ishikawa N, Tokumoto T, Harano M, Otsubo S, Suzuki K, Goya N, Yagisawa T, Nakazawa H, Fuchinoue S, Toma H.
    Transplant Proc; 1999 Nov; 31(7):2870-1. PubMed ID: 10578320
    [No Abstract] [Full Text] [Related]

  • 4. Tacrolimus therapy for ABO-incompatible kidney transplantation.
    Takahashi K, Saito K, Sonda K, Nakagawa Y, Katagiri A, Tomita Y, Tanigawa T, Takeda M.
    Transplant Proc; 1998 Jun; 30(4):1219-20. PubMed ID: 9636495
    [No Abstract] [Full Text] [Related]

  • 5. Effects of deoxyspergualin (DSG) administered in the chronic phase following kidney transplantation.
    Fudaba Y, Fukuda Y, Yamamoto H, Ohdan H, Shintaku S, Shibata S, Miyata Y, Marubayashi S, Asahara T, Dohi K.
    Transplant Proc; 1998 Nov; 30(7):3582-3. PubMed ID: 9838569
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effectiveness of 15-deoxyspergualin on renal graft rejection.
    Kozaki K, Matsuno N, Sakurai E, Tamaki I, Furuhashi K, Saito A, Yoshida M, Miyamoto K, Kozaki M.
    Transplant Proc; 1994 Aug; 26(4):1903-4. PubMed ID: 8066619
    [No Abstract] [Full Text] [Related]

  • 10. Usefulness of 15-deoxyspergualin for rejection in renal transplantation.
    Kozaki K, Kozaki M, Nagao T.
    Transplant Proc; 1999 Aug; 31(1-2):1138-9. PubMed ID: 10083509
    [No Abstract] [Full Text] [Related]

  • 11. Experience with administration of 15-deoxyspergualin in rejection in kidney transplant recipients.
    Jiang H, Takahara S, Takano Y, Kokado Y, Kameoka H, Moutabarrik A, Ishibashi M, Okuyama A, Sonoda T.
    Transplant Proc; 1992 Oct; 24(5):1726-9. PubMed ID: 1412813
    [No Abstract] [Full Text] [Related]

  • 12. Effect of deoxyspergualin on acute and chronic rejection in renal transplantation.
    Nomura Y, Tomikawa S, Beck Y, Nishimura Y, Meigata K, Ando Y, Kikuchi K.
    Transplant Proc; 1998 Nov; 30(7):3580-1. PubMed ID: 9838568
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Excellent long-term survival of low-risk, first renal allografts using cyclosporine/azathioprine double therapy.
    Faull RJ, Bannister KM, Russ GR, Mathew TH, Clarkson AR.
    Transplant Proc; 1999 Nov; 31(1-2):1155-6. PubMed ID: 10083516
    [No Abstract] [Full Text] [Related]

  • 18. Remarkable recovery from rejection by treatment with deoxyspergualin and methylprednisolone on canine kidney allografts.
    Suzuki S, Hayashi R, Niiya S, Kenmochi T, Fukuoka T, Amemiya H.
    Transplant Proc; 1991 Feb; 23(1 Pt 1):545-6. PubMed ID: 1990606
    [No Abstract] [Full Text] [Related]

  • 19. Low-dose tacrolimus (FK 506)-based immunosuppressive protocol in living donor renal transplantation.
    Kokado Y, Takahara S, Kyo M, Ichimaru N, Toki K, Wang JD, Okuyama A.
    Transplant Proc; 1999 Feb; 31(1-2):1151-4. PubMed ID: 10083515
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.